New Risk • Jun 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (RM104.6m market cap, or US$25.3m). Reported Earnings • May 26
First quarter 2026 earnings released: EPS: RM0 (vs RM0.001 loss in 1Q 2025) First quarter 2026 results: EPS: RM0 (improved from RM0.001 loss in 1Q 2025). Revenue: RM21.4m (up 19% from 1Q 2025). Net income: RM118.0k (up RM957.0k from 1Q 2025). Profit margin: 0.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Announcement • Apr 29
DC Healthcare Holdings Berhad, Annual General Meeting, Jun 16, 2026 DC Healthcare Holdings Berhad, Annual General Meeting, Jun 16, 2026, at 11:00 Singapore Standard Time. Location: kinrara room 1, kinrara golf club, jalan kinrara 6, bandar kinrara 6, 47100 puchong, selangor, Malaysia Reported Earnings • Mar 02
Full year 2025 earnings released: EPS: RM0 (vs RM0.02 loss in FY 2024) Full year 2025 results: EPS: RM0 (improved from RM0.02 loss in FY 2024). Revenue: RM86.1m (up 54% from FY 2024). Net income: RM211.0k (up RM19.9m from FY 2024). Profit margin: 0.2% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. New Risk • Feb 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 43% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (RM149.4m market cap, or US$38.0m). Reported Earnings • Nov 26
Third quarter 2025 earnings released: EPS: RM0.002 (vs RM0.002 loss in 3Q 2024) Third quarter 2025 results: EPS: RM0.002 (up from RM0.002 loss in 3Q 2024). Revenue: RM25.7m (up 63% from 3Q 2024). Net income: RM2.30m (up RM4.45m from 3Q 2024). Profit margin: 8.9% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Board Change • Sep 01
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Non Executive Director Siow Goh was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 28
Second quarter 2025 earnings released: RM0.001 loss per share (vs RM0.007 loss in 2Q 2024) Second quarter 2025 results: RM0.001 loss per share (improved from RM0.007 loss in 2Q 2024). Revenue: RM20.6m (up 48% from 2Q 2024). Net loss: RM1.03m (loss narrowed 85% from 2Q 2024). New Risk • Aug 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 56% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (RM139.5m market cap, or US$33.1m). Announcement • Jun 19
DC Healthcare Holdings Berhad Announces Cessation of Office of Sim Lee San as Independent and Non Executive Member of Nomination Committee, Effective 17 June 2025 DC Healthcare Holdings Berhad announced the cessation of office of Miss Sim Lee San as Independent and Non Executive Member of Nomination Committee, effective 17 June 2025. Age is 48. Composition of Nomination Committee (After Change): The composition of the Nomination Committee shall be as follows: Datin Rekha A/P Palanysamy (Chairperson). Reported Earnings • May 22
First quarter 2025 earnings released: RM0.001 loss per share (vs RM0.008 loss in 1Q 2024) First quarter 2025 results: RM0.001 loss per share (improved from RM0.008 loss in 1Q 2024). Revenue: RM17.9m (up 89% from 1Q 2024). Net loss: RM839.0k (loss narrowed 89% from 1Q 2024). Announcement • Apr 29
DC Healthcare Holdings Berhad, Annual General Meeting, Jun 17, 2025 DC Healthcare Holdings Berhad, Annual General Meeting, Jun 17, 2025, at 11:00 Singapore Standard Time. Location: the majestic hotel kuala lumpur, 5, jalan sultan hishamuddin, tasik perdana, wilayah persekutuan kuala lumpur, 50000 kuala lumpur, Malaysia New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 46% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Market cap is less than US$100m (RM149.4m market cap, or US$33.4m). Reported Earnings • Feb 26
Full year 2024 earnings released: RM0.02 loss per share (vs RM0.003 profit in FY 2023) Full year 2024 results: RM0.02 loss per share (down from RM0.003 profit in FY 2023). Revenue: RM55.8m (down 18% from FY 2023). Net loss: RM19.7m (down RM22.3m from profit in FY 2023). Reported Earnings • Nov 27
Third quarter 2024 earnings released: RM0.002 loss per share (vs RM0.001 loss in 3Q 2023) Third quarter 2024 results: RM0.002 loss per share (further deteriorated from RM0.001 loss in 3Q 2023). Revenue: RM15.8m (down 9.6% from 3Q 2023). Net loss: RM2.15m (loss widened 91% from 3Q 2023). Reported Earnings • Aug 29
Second quarter 2024 earnings released Second quarter 2024 results: RM0.007 loss per share. Net loss: RM6.71m (flat on 2Q 2023). Reported Earnings • May 28
First quarter 2024 earnings released First quarter 2024 results: RM0.008 loss per share. Net loss: RM7.91m (flat on 1Q 2023). Announcement • May 01
DC Healthcare Holdings Berhad, Annual General Meeting, Jun 11, 2024 DC Healthcare Holdings Berhad, Annual General Meeting, Jun 11, 2024, at 11:00 Singapore Standard Time. Agenda: To receive the Audited Financial Statements for the financial year ended 31 December 2023 together with the Reports of the Directors and Auditors thereon; To re-elect the Datuk Dr. Mohd Noor Bin Awang who shall retire by rotation pursuant to Clause 106(1) of the Company's Constitution and being eligible, has offered himself for re-election; To re-elect the Dr. Chong Tze Sheng who shall retire by rotation pursuant to Clause 106(1) of the Company's Constitution and being eligible, has offered himself for re-election. Announcement • Feb 28
DC Healthcare Holdings Berhad Announces the Appointment of Nurul Syahidah Binti Mat Tahil as Joint Secretary DC Healthcare Holdings Berhad announced the appointment of Nurul Syahidah Binti Mat Tahil as Joint Secretary of the company, effective from 27 Feb. 2024. New Risk • Nov 23
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: RM438.4m (US$93.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (RM438.4m market cap, or US$93.7m). Announcement • Nov 02
Dc Healthcare Holdings Berhad Announces Promotion of Mah Lai Heng as Chief Operating Officer DC Healthcare Holdings Berhad announced promotion of Madam Mah Lai Heng from Senior Operation Manager to Group Chief Operating Officer with effect from 1 November 2023. Age 64. Qualifications: Masters-Business Administration-Henley Management College, Reading University, UK, Others-Advanced Critical Care Nursing-University South Australia, Adelaide Australia and Degree-Nursing Science-University Malaya. Working experience:Ms. Mah Lai Heng has 27 years of experience in Healthcare Industries. Her area of expertise including the Hospital Management, Hospital Operation, Hospital, Ambulatory Care Centers & GP Clinics Licensing & Commissioning, Clinical & Quality Management etc. Below are the list of her position held in service1. December 2022 - current: Senior Operation Manager of Klinik Dr Chong Sdn. Bhd.2. May 2021 - November 2022: Appointed as BP Healthcare Group Chief Operating Officer3. September 2018 - October 2020: General Manager of Shanghai United Family Hospital & Clinics5. January 2015 - Aug. 2018: Senior General Manager, Business Operation Services, KPJ Healthcare Berhad, Chairman, KPJ Group Central Licensing Committee, Regional Executive Director East Malaysia6. February 2013 - September 2018: Regional Executive Director, East Malaysia KPJ Hospitals Sabah & Sarawak, East Coast KPJ Kuantan Specialist Hospital & KPJ Pahang Specialist Hospital (Total 5 operational hospitals and 2 new hospital development projects)7. July 2011 - January 2015: Senior General Manager, Group Clinical & Quality Services, KPJ Healthcare Berhad8. July 2008 - June 2011: Chief Executive Officer, KPJ Penang Specialist Hospital9. February 2006 - June 2008: General Manager, Kuching Specialist Hospital10. May 2005 - January 2006: Senior Corporate Executive, KPJ Group Strategic Planning Division11. May 2000 - May 2005: Director of Nursing, Ipoh Specialist Hospital12. January 1996 - June 2004: Adjunct Lecturer for University South Australia, Advance Critical Care Nursing Program13. August 1995 - April 2000: Nurse Lecturer, Puteri Nursing College, PJ (now known as KPJ University College)14. July 1989 - August 1995: Registered Nurse, Cardiac Coronary Care and Intensive Care Units, Hospital Ipoh16. July 1984 - June 1989: Registered Nurse, Medical & Surgical Wards, Hospital Ipoh. Board Change • Jul 18
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. MD & Director Ngan Lai is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.